Selected research
Industry Research
Human Coagulation Factor XIII Industry Research Report 2026
Market perspective
The global Human Coagulation Factor XIII market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Human Coagulation Factor XIII is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Human Coagulation Factor XIII is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Human Coagulation Factor XIII is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Human Coagulation Factor XIII include Cell Sciences, Inc., CSL Behring, Enzyme Research Laboratories Inc., Invitrogen (Thermo Fisher Scientific Inc.), Sino Biological, Inc., ZEDIRA GmbH and Merck KGaA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Human Coagulation Factor XIII market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Human Coagulation Factor XIII Market by Company
Cell Sciences, Inc.
CSL Behring
Enzyme Research Laboratories Inc.
Invitrogen (Thermo Fisher Scientific Inc.)
Sino Biological, Inc.
ZEDIRA GmbH
Merck KGaA
Human Coagulation Factor XIII Segment by Type
Lyophilized Powder
Liquid
Human Coagulation Factor XIII Segment by Application
Medical Research
Surgery
Disease Treatment
Others
Human Coagulation Factor XIII Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor XIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor XIII and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor XIII.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Coagulation Factor XIII manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Coagulation Factor XIII by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Coagulation Factor XIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lyophilized Powder
- Liquid
Applications
- Medical Research
- Surgery
- Disease Treatment
- Others
Companies covered
- Cell Sciences, Inc.
- CSL Behring
- Enzyme Research Laboratories Inc.
- Invitrogen (Thermo Fisher Scientific Inc.)
- Sino Biological, Inc.
- ZEDIRA GmbH
- Merck KGaA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Human Coagulation Factor XIII Market Size (2021-2032)
- 2.2.2 Global Human Coagulation Factor XIII Sales (2021-2032)
- 2.2.3 Global Human Coagulation Factor XIII Market Average Price (2021-2032)
- 2.3 Human Coagulation Factor XIII by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Lyophilized Powder
- 2.3.3 Liquid
- 2.4 Human Coagulation Factor XIII by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medical Research
- 2.4.3 Surgery
- 2.4.4 Disease Treatment
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Human Coagulation Factor XIII Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Human Coagulation Factor XIII Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Human Coagulation Factor XIII Revenue of Manufacturers (2021-2026)
- 3.4 Global Human Coagulation Factor XIII Average Price by Manufacturers (2021-2026)
- 3.5 Global Human Coagulation Factor XIII Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Human Coagulation Factor XIII, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Human Coagulation Factor XIII, Product Type & Application
- 3.8 Global Manufacturers of Human Coagulation Factor XIII, Established Date
- 3.9 Global Human Coagulation Factor XIII Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Cell Sciences, Inc.
- 4.1.1 Cell Sciences, Inc. Company Information
- 4.1.2 Cell Sciences, Inc. Business Overview
- 4.1.3 Cell Sciences, Inc. Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Cell Sciences, Inc. Human Coagulation Factor XIII Product Portfolio
- 4.1.5 Cell Sciences, Inc. Recent Developments
- 4.2 CSL Behring
- 4.2.1 CSL Behring Company Information
- 4.2.2 CSL Behring Business Overview
- 4.2.3 CSL Behring Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CSL Behring Human Coagulation Factor XIII Product Portfolio
- 4.2.5 CSL Behring Recent Developments
- 4.3 Enzyme Research Laboratories Inc.
- 4.3.1 Enzyme Research Laboratories Inc. Company Information
- 4.3.2 Enzyme Research Laboratories Inc. Business Overview
- 4.3.3 Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Product Portfolio
- 4.3.5 Enzyme Research Laboratories Inc. Recent Developments
- 4.4 Invitrogen (Thermo Fisher Scientific Inc.)
- 4.4.1 Invitrogen (Thermo Fisher Scientific Inc.) Company Information
- 4.4.2 Invitrogen (Thermo Fisher Scientific Inc.) Business Overview
- 4.4.3 Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Product Portfolio
- 4.4.5 Invitrogen (Thermo Fisher Scientific Inc.) Recent Developments
- 4.5 Sino Biological, Inc.
- 4.5.1 Sino Biological, Inc. Company Information
- 4.5.2 Sino Biological, Inc. Business Overview
- 4.5.3 Sino Biological, Inc. Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sino Biological, Inc. Human Coagulation Factor XIII Product Portfolio
- 4.5.5 Sino Biological, Inc. Recent Developments
- 4.6 ZEDIRA GmbH
- 4.6.1 ZEDIRA GmbH Company Information
- 4.6.2 ZEDIRA GmbH Business Overview
- 4.6.3 ZEDIRA GmbH Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 ZEDIRA GmbH Human Coagulation Factor XIII Product Portfolio
- 4.6.5 ZEDIRA GmbH Recent Developments
- 4.7 Merck KGaA
- 4.7.1 Merck KGaA Company Information
- 4.7.2 Merck KGaA Business Overview
- 4.7.3 Merck KGaA Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck KGaA Human Coagulation Factor XIII Product Portfolio
- 4.7.5 Merck KGaA Recent Developments
5 Global Human Coagulation Factor XIII Market Scenario by Region
- 5.1 Global Human Coagulation Factor XIII Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Human Coagulation Factor XIII Sales by Region: 2021-2032
- 5.2.1 Global Human Coagulation Factor XIII Sales by Region: 2021-2026
- 5.2.2 Global Human Coagulation Factor XIII Sales by Region: 2027-2032
- 5.3 Global Human Coagulation Factor XIII Revenue by Region: 2021-2032
- 5.3.1 Global Human Coagulation Factor XIII Revenue by Region: 2021-2026
- 5.3.2 Global Human Coagulation Factor XIII Revenue by Region: 2027-2032
- 5.4 North America Human Coagulation Factor XIII Market Facts & Figures by Country
- 5.4.1 North America Human Coagulation Factor XIII Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Human Coagulation Factor XIII Sales by Country (2021-2032)
- 5.4.3 North America Human Coagulation Factor XIII Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Human Coagulation Factor XIII Market Facts & Figures by Country
- 5.5.1 Europe Human Coagulation Factor XIII Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Human Coagulation Factor XIII Sales by Country (2021-2032)
- 5.5.3 Europe Human Coagulation Factor XIII Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Human Coagulation Factor XIII Market Facts & Figures by Country
- 5.6.1 Asia Pacific Human Coagulation Factor XIII Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Human Coagulation Factor XIII Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Human Coagulation Factor XIII Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Human Coagulation Factor XIII Market Facts & Figures by Country
- 5.7.1 South America Human Coagulation Factor XIII Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Human Coagulation Factor XIII Sales by Country (2021-2032)
- 5.7.3 South America Human Coagulation Factor XIII Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Human Coagulation Factor XIII Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Human Coagulation Factor XIII Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Human Coagulation Factor XIII Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Human Coagulation Factor XIII Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Human Coagulation Factor XIII Sales by Type (2021-2032)
- 6.1.1 Global Human Coagulation Factor XIII Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Human Coagulation Factor XIII Sales Market Share by Type (2021-2032)
- 6.2 Global Human Coagulation Factor XIII Revenue by Type (2021-2032)
- 6.2.1 Global Human Coagulation Factor XIII Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Human Coagulation Factor XIII Revenue Market Share by Type (2021-2032)
- 6.3 Global Human Coagulation Factor XIII Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Human Coagulation Factor XIII Sales by Application (2021-2032)
- 7.1.1 Global Human Coagulation Factor XIII Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Human Coagulation Factor XIII Sales Market Share by Application (2021-2032)
- 7.2 Global Human Coagulation Factor XIII Revenue by Application (2021-2032)
- 7.2.1 Global Human Coagulation Factor XIII Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Human Coagulation Factor XIII Revenue Market Share by Application (2021-2032)
- 7.3 Global Human Coagulation Factor XIII Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Human Coagulation Factor XIII Value Chain Analysis
- 8.1.1 Human Coagulation Factor XIII Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Human Coagulation Factor XIII Production Mode & Process
- 8.2 Human Coagulation Factor XIII Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Human Coagulation Factor XIII Distributors
- 8.2.3 Human Coagulation Factor XIII Customers
9 Global Human Coagulation Factor XIII Analyzing Market Dynamics
- 9.1 Human Coagulation Factor XIII Industry Trends
- 9.2 Human Coagulation Factor XIII Industry Drivers
- 9.3 Human Coagulation Factor XIII Industry Opportunities and Challenges
- 9.4 Human Coagulation Factor XIII Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst